A systematic review of 69 peer-reviewed studies reports 333 individual cases and early population data linking COVID-19 vaccination or infection to unusually rapid cancer progression or new onset of hematologic and solid tumors. While not proving causation, these consistent clinical observations constitute an early safety signal. The findings highlight an urgent need for rigorous longitudinal and mechanistic studies to clarify any potential risk.